Itr Laboratories Canada Inc

Closed

Call

Website

19601 Avenue Clark Graham

Baie-D'Urfé, Québec H9X 3T1

+1 (514) 457-7400

https://www.itrlab.com

ITR Laboratories Canada Inc., located in Baie-D'Urfé, Québec, is a leading contract research organization with over 30 years of experience in providing specialized services in efficacy, toxicology, and laboratory services for a wide range of molecules. Their team of highly trained scientists utilizes state-of-the-art facilities and instrumentation to maximize the value of research investments for clients worldwide.

Committed to animal welfare, ITR Laboratories conducts preclinical research programs with a focus on creating strong partnerships with clients to ensure successful project outcomes. Their comprehensive service offerings span from single-dose acute studies to carcinogenicity assessments, addressing various toxicology needs effectively.

Generated from the website

Own this business?

See a problem?

Testing laboratories, Biological research

Abich Inc

Abich Inc is a company located in Montréal, Québec, utilizing the IP address 83.137.232.137 for its web server operations. Their presence indicates an engagement in digital services, though specific offerings are not detailed in the provided information. The mention of the default web server page suggests that Abich Inc may be in the initial stages of establishing their online identity. This detail hints at potential developments in their digital presence and services in the future. Generated from the website

Testing laboratories, Biological research

Alethia Biotherapeutics Inc

Alethia Biotherapeutics Inc, based in Montréal, QC, is focused on developing innovative cancer therapies, particularly targeting epithelial to mesenchymal transition (EMT) to combat chemotherapy resistance and metastatic tumor invasion. Their lead product, AB16B5, is a humanized IgG2 monoclonal antibody designed to inhibit EMT, showing promising preclinical results in enhancing chemotherapy response and reducing tumor invasion. The company has received FDA authorization to initiate Phase 2 development for AB16B5, marking a significant milestone in its research efforts. Alethia Biotherapeutics is set to present its findings at the Annual ASCO Meeting, highlighting the potential of their EMT inhibitor in treating metastatic non-small cell lung cancer. Generated from the website

Biological research, Testing laboratories

Institut De Recherches Cliniques De Montreal

Institut De Recherches Cliniques De Montreal is a research institute based in Montréal, QC, specializing in clinical research and scientific studies. With a focus on advancing medical knowledge and improving patient care, the institute collaborates with healthcare professionals and researchers to conduct innovative research projects. Generated from their business information